BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27602138)

  • 1. Targeted silencing of CXCR4 inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Duan Y; Zhang S; Wang L; Zhou X; He Q; Liu S; Yue K; Wang X
    Oncol Lett; 2016 Sep; 12(3):2055-2061. PubMed ID: 27602138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The experimental study of CXC subfamily receptor 4 modulating oral squamous cell carcinoma epithelial-mesenchymal transition to influence lymphatic metastasis in vitro].
    Zhang S; Wang B; Zhou X; Yue K; Wang X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Mar; 49(3):171-6. PubMed ID: 24820786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CRNDE regulates cell proliferation, migration, invasion, epithelial-mesenchymal transition and apoptosis in oral squamous cell carcinoma.
    Dai J; Mu JW; Mu H
    Oncol Lett; 2019 Mar; 17(3):3330-3340. PubMed ID: 30867767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
    Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X
    Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
    Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Zhang S; Zhou X; Wang B; Zhang K; Liu S; Yue K; Zhang L; Wang X
    Oral Oncol; 2014 Sep; 50(9):809-17. PubMed ID: 24998140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
    Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L; Qin XP; Zhao XX; Wang W
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
    Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
    Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial-mesenchymal transition via the hedgehog signaling pathway.
    Song Q; Wang B; Liu M; Ren Z; Fu Y; Zhang P; Yang M
    Exp Cell Res; 2019 Sep; 382(1):111450. PubMed ID: 31152708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANXA1 affects cell proliferation, invasion and epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Wan YM; Tian J; Qi L; Liu LM; Xu N
    Exp Ther Med; 2017 Nov; 14(5):5214-5218. PubMed ID: 29201239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor Effect of
    Chen H; Wang C; Qi M; Ge L; Tian Z; Li J; Zhang M; Wang M; Huang L; Tang X
    Front Pharmacol; 2017; 8():870. PubMed ID: 29218012
    [No Abstract]   [Full Text] [Related]  

  • 15. KLF7 overexpression in human oral squamous cell carcinoma promotes migration and epithelial-mesenchymal transition.
    Ding X; Wang X; Gong Y; Ruan H; Sun Y; Yu Y
    Oncol Lett; 2017 Apr; 13(4):2281-2289. PubMed ID: 28454392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma.
    Meng L; Zhao Y; Bu W; Li X; Liu X; Zhou D; Chen Y; Zheng S; Lin Q; Liu Q; Sun H
    Cell Prolif; 2020 Aug; 53(8):e12859. PubMed ID: 32588946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JMJD3 promotes the epithelial-mesenchymal transition and migration of glioma cells via the CXCL12/CXCR4 axis.
    Zou S; Zhang D; Xu Z; Wen X; Zhang Y
    Oncol Lett; 2019 Dec; 18(6):5930-5940. PubMed ID: 31788067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.